<DOC>
	<DOC>NCT02244346</DOC>
	<brief_summary>Study to evaluate the safety profile of SecotexÂ® in the improvement of the symptoms of Benign Prostatic Hyperplasia in real clinical practice</brief_summary>
	<brief_title>Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Patients of any age with a diagnosis of symptomatic Benign Prostatic Hyperplasia (BPH) Patients with symptoms, that according to physician require medical treatment to improve quality of life Patients could be naive to treatment or could be on treatment with other drugs but have not responded adequately to treatment Patients with known hypersensitivity to Tamsulosin, or any other component of the product Patients with a history of orthostatic hypotension or severe liver failure</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>